Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Report on the work of independent directors in 2021
Shareholders and shareholder representatives:
As an independent director, during my term of office in 2021, I strictly complied with relevant regulations and requirements
Perform their duties diligently, give full play to the role of independent directors and perform their obligations independently and impartially. During the reporting period, I was reappointed on April 19, 2021 according to relevant regulations due to the expiration of six years of re-election in the company
No longer holds the position of independent director from the date of. Now I will perform the duties of independent director during my term of office in 2021
The situation is reported as follows:
1、 Attendance at the board of directors and shareholders’ meeting
This year, I attended the board of directors and shareholders’ meeting on time, carefully considered various proposals and independently expressed my opinions, without voting against or abstaining from voting.
(I) during my term of office in 2021, the company held three meetings of the board of directors. For details, see
The following table:
The independent director shall attend the on-site meeting by means of communication, whether the name is continuous, the number of times of attendance, the number of times of attendance, the number of times of absence, and the number of times of not attending the meeting in person
He Suying 3 1 2 0 0 0 no
(II) during my tenure in 2021, the company held the first extraordinary general meeting of shareholders in 2021
I attended the 2020 annual general meeting.
2、 Independent opinions
In 2021, I actively attended relevant meetings, carefully considered various proposals and adopted a reasonable and cautious attitude,
Make an independent and impartial judgment. The independent opinions jointly expressed with other independent directors on relevant matters are as follows:
Comment serial number event time
type
1. On January 5, 2021, it was agreed to purchase the liability insurance of directors, supervisors and senior managers
Adjustment plan for non-public offering of A-Shares of the company in 2020
2. Matters agreed on January 19, 2021
3. The company’s 2020 profit distribution plan was approved on March 28, 2021
4. With regard to the remuneration of directors and senior managers of the company in 2020, it was agreed on March 28, 2021
5. The company’s 2020 internal control self-evaluation report was approved on March 28, 2021
6. On the renewal of the company’s audit institution in 2021, it was agreed on March 28, 2021
7. On the change of accounting policy, it was agreed on March 28, 2021
8. On the nomination and addition of candidates for independent directors of the 5th board of directors of the company, it was agreed on March 28, 2021
9. Consent on using its own idle funds to invest in financial products on March 28, 2021
10. On the company’s external guarantee and funds occupied by related parties, it was agreed on March 28, 2021
3、 Actively participate in the work of the special committee
As the convener of the audit committee of the board of directors and a member of the remuneration and assessment committee, in 2021, he organized and held an audit committee meeting to supervise the implementation of internal audit, supervise the internal control of the company, review the regular financial reports of the company and pay attention to the progress of major events of the company. As a member of the remuneration and assessment committee, check the performance of directors and senior executives, and assess the payment of annual remuneration of directors and senior executives.
4、 On site inspection of the company
As an independent director, I learned about the company’s production and operation status, supervised the construction and implementation of the company’s internal control system, and checked the implementation of the resolutions of the board of directors through on-site investigation, listening to reports, reviewing documents and other forms. During my tenure, I spent a total of 3 days on-site inspection. Through on-site inspection of the company’s financial and audit departments, I checked the construction and implementation of financial system, listened to the work reports of relevant principals and gave guidance; At the same time, always pay attention to the impact of external environment and market changes on the company, and pay close attention to the reports related to the company in the media; Keep in touch with other directors, supervisors, management and relevant personnel of the company, master the operation and management dynamics of the company, and ensure that the supervision and guidance functions of independent directors are brought into play.
5、 Other work done in protecting the rights and interests of investors
1. Pay attention to the company’s internal control and corporate governance structure
As an independent director, I am diligent and responsible, actively communicate with relevant personnel of the company, and timely understand the progress of the company’s production and operation, financial status and major events; Supervise and inspect the performance of senior managers; For major issues that need to be considered by the board of directors, carefully review relevant materials, and actively ask relevant personnel if in doubt. On this basis, use professional knowledge to exercise voting rights independently, objectively and impartially; Investigate the company’s financial operation, capital transactions, major foreign investment, related party transactions and other major matters, and earnestly perform the duties of independent directors.
2. Supervise and inspect the information disclosure of the company
I continue to pay close attention to the company’s information disclosure, urge the company to perform its information disclosure obligations truthfully, accurately and completely in strict accordance with the requirements of relevant laws and regulations and the company’s information disclosure system, and earnestly safeguard the right to know of investors, especially small and medium-sized investors.
6、 And training
During my tenure, I have continuously strengthened my study of the laws, regulations and rules of the CSRC and Shenzhen Stock Exchange, improved my understanding of the corporate governance structure and the protection of the rights and interests of public shareholders, improved my ability to perform my duties, made use of my professional knowledge, provided more constructive suggestions for the development of the company and safeguarded the legitimate rights and interests of the company and shareholders.
7、 Other working conditions
As an independent director, I did not propose to convene the board of directors or extraordinary general meeting of shareholders in 2021, nor did I independently hire external audit institutions and consulting companies to audit and consult on specific matters of the company; Through the proposal of the audit committee, Daxin Certified Public Accountants (special general partnership) is proposed to be the audit institution of the company in 2021.
8、 Problems and suggestions of the company
The company has established an internal governance structure, standardized operation and sound system in accordance with relevant laws and regulations. It is suggested that the company should continue to standardize governance, continuously improve the company’s operation and management level, and lay a solid foundation for sustainable and healthy development.
9、 Contact information
Name: he Suying
mail box: [email protected].
In 2021, my term of re-election in the company expires for six years, and I will no longer serve as an independent director of the company according to relevant regulations. I would like to thank the board of directors, the board of supervisors and the management of the company for their active cooperation during my performance of duties! Under the leadership of the board of directors, we sincerely hope to continue to enhance the profitability of the company and create better returns for all shareholders.
It is hereby reported
Signature of independent director:
He Suying
March 25, 2002
